Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies

Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies

Halil Yildiz,1 Sarah Bailly,2 Eric Van Den Neste,2 Jean Cyr Yombi1 1Departement of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint Luc, Bruxelles, Belgique; 2Departement of Hematology, Cliniques Universitaires Saint Luc, Bruxelles, BelgiqueCorrespondence: Halil YildizDepart...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yildiz H, Bailly S, Van Den Neste E, Yombi JC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
aemophagocytic lymphohistiocytosis
refractory
doxorubicin
etoposide
methylprednisolone regimen
hematopoietic stem cell transplantation
emapalumab
ruxolutinib
alemtuzumab
macrophage activating syndrome
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/c7d7a3626ec343db94f6287997856bef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c7d7a3626ec343db94f6287997856bef

Ejemplares similares